Scribe Therapeutics achieves second success milestone for in vivo program in collaboration with Eli Lilly and Company ...
A new light-based sensor can spot incredibly tiny amounts of cancer biomarkers in blood, raising the possibility of earlier ...
Pharma R&D is shifting to platform models, enhancing efficiency and innovation, as highlighted in EY-Parthenon India's report ...
ZUG, Switzerland and BOSTON, Feb. 12, 2026 (GLOBE NEWSWIRE) -- CRISPR Therapeutics (Nasdaq: CRSP) today reported financial ...
EY-Parthenon India on Tuesday unveiled its latest report, “Pharma’s New Architecture: Where Novel Science Meets AI and ...
Oceanic ecosystems are increasingly threatened by global warming, which causes coral bleaching, species migration and, ...
CRISPR Therapeutics (Nasdaq: CRSP) today reported financial results for the fourth quarter and full year ended December 31, 2025. "As we ...
A new CRISPR-powered light sensor can detect the faintest whispers of cancer in a single drop of blood.
Last year a ten-month old baby in the US was the first person in the world to have their rare genetic disease effectively cured through the use of CRISPR gene editing technology. But the roll out of ...
Author Gabriel Rosenberg advocates that the structure of industrial food production and distribution is key to achieving the best nutrition and food security. The post ‘Feed the People' looks to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results